# AriMed Advisors

> AriMed Advisors is a VC fund in Shanghai backing Biotechnology, Medical and Health Care. See 2 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Shanghai, China
- Total investments: 2
- Last investment: Mar 2022
- Lead investor: 0%
- Last updated: Aug 2026
- Website: http://www.arimedcapital.com

AriMed Advisors is a VC fund in Shanghai focused on Biotechnology and Medical. AriMed Advisors is one of the leading financial advisory and strategy consulting firms to corporations within Chinese healthcare & life sciences and related industries. They provide an integrated advisory service in raising capital, growth strategy, M&A and divestiture transactions, and initial public offerings. The combination of industryleadership, deep sector expertise and long-term growth strategies drives business transformation. Their firm has a unique specialization in hospital management and development strategy.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 2 | 100% |
| Medical | 1 | 50% |
| Health Care | 1 | 50% |

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 1 | 50% |
| Series A | 1 | 50% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| China | 1 | 50% |
| United States | 1 | 50% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| ArrePath | ArrePath is an anti-infective drug discovery company addressing the global health challenge of drug resistant infections. | $20M | Seed | Mar 03, 2022 |  |
| Ligatech Bioscience | Ligatech Bioscience is an intrusive consumables developer specializing in the development and manufacture of medical devices for the field of sports medicine, as well as the development and production of biomedical materials and products. A production line for artificial ligaments and artificial ligament fixation systems has been established. Andprovide users with relevant technical advice and technical services. |  | Series A | Nov 09, 2017 |  |

2 of 2 investments shown.

## Co-investors
- [3E Bioventures](https://shizune.co/investors/profile/3e-bioventures) — VC Fund, 1 deal together
- [Boehringer Ingelheim Venture Fund](https://shizune.co/investors/profile/boehringer-ingelheim-venture-fund) — VC Fund, 1 deal together
- [Innospark Ventures](https://shizune.co/investors/profile/innospark-ventures) — VC Fund, 1 deal together
- [Insight Partners](https://shizune.co/investors/profile/insight-partners) — VC Fund, 1 deal together
- Nor'easter Ventures — VC Fund, 1 deal together
- [PTX Capital](https://shizune.co/investors/profile/ptx-capital) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does AriMed Advisors invest in?

AriMed Advisors invests primarily in Biotechnology, Medical and Health Care startups, most often at Seed and Series A stage. Most of the 2 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did AriMed Advisors last invest?

The most recent investment recorded for AriMed Advisors closed in Mar 2022. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co